| Cat.No. | Name | Information |
|---|---|---|
| M1781 | Adezmapimod (SB203580) | Adezmapimod (SB203580) is a P38 MAPK inhibitor with an IC50 of 0.3-0.5 μM, which is 10 times less selective than SAPK3(106T) and SAPK4(106T), and inhibits PKB phosphorylation with an IC50 of 3-5 μM. |
| M2062 | SB 202190 | SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively. |
| M1675 | BIRB796 | BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM. |
| M2317 | VX-702 | VX-702 is a highly selective inhibitor of p38 MAPKα with IC50 of 4-20 nM. |
| M2136 | PH-797804 | PH-797804 is a highly selective and potent inhibitor of p38 MAP kinase with IC50 of 26 nM. |
| M1675 | BIRB796 | BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM. |
| M1556 | Hesperetin | Hesperetin is a potent and broad-spectrum inhibitor against human UGT activity. |
| M54757 | BSJ-04-122 | BSJ-04-122 is a covalent MKK4/7 dual inhibitor. BSJ-04-122 inhibits MKK4 and MKK7 with IC50 values of 4 nM and 181 nM, respectively. |
| M54427 | OVA-E1 peptide TFA | OVA-E1 peptide TFA, is an antagonist variant of SIINFEKL [OVA (257-264). |
| M54176 | MBP MAPK Substrate | MBP MAPK Substrate is used as an exogenous substrate for MAPK. |
| M52814 | OVA-E1 peptide | OVA-E1 peptide, is an antagonist variant of SIINFEKL [OVA (257-264). |
| M52813 | EGF-R (661-681) T669 Peptide | EGF-R (661-681) T669 Peptide is a MAPK substrate that can used to measure MAPK catalytic activity. |
| M49726 | Anti-inflammatory agent 35 | Anti-inflammatory agent 35 is an orally active curcumin analogue with anti-inflammatory activity. |
| M45284 | AMG-548 dihydrochloride | AMG-548 dihydrochloride is an orally active, selective inhibitor of p38α (Ki=0.5 nM), slightly selective for p38β (Ki=36 nM), and >1000-fold selective for p38γ and p38δ. AMG-548 dihydrochloride also potently inhibits whole blood LPS-stimulated TNFα (IC50=3 nM). LPS-stimulated TNFα (IC50=3 nM). In addition, AMG-548 dihydrochloride inhibits Wnt signaling through direct inhibition of Casein kinase 1 isoforms δ and ε. |
| M44944 | Natsudaidain | Natsudaidain is a kind of polymethoxyflavone. |
| M44747 | 5,6,7-Trimethoxyflavone | 5,6,7-Trimethoxyflavone is a novel p38-α MAPK inhibitor with an anti-inflammatory effect. |
| M44718 | 3,5-Di-O-caffeoylquinic acid methyl ester | Macranthoin G is an inhibitor of p38 MAPK. |
| M42151 | p38 Kinase inhibitor 5 | p38 Kinase inhibitor 5 (AA6) is a potent p38 kinase inhibitor with an IC50 of 403.57 nM. |
| M42150 | p38α inhibitor 4 | p38α inhibitor 4 is a selective and allosteric p38α inhibitor with an IC50 value of 1.2 μM. |
| M42149 | SX 011 | SX 011 is a p38 inhibitor with IC50s of 9 nM and 90 nM against p38α and p38β, respectively. |
| M42148 | Akt/NF-κB/MAPK-IN-1 | Akt/NF-κB/MAPK-IN-1 is a potent and orally active inhibitor against NO (IC50=7.70 μM) with no significant toxicity. |
| M42147 | Z16078526 | Z16078526 induces endogenous Ucp1 expression, promotes p38 MAPK phosphorylation and lipolysis in primary mouse brown adipocytes. |
| M42146 | SB 220025 | SB 220025 is a reversible, orally active, cell-permeable, ATP-competitive and selective human p38 MAPK inhibitor (IC50 = 60 nM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
